Ferrandina, Gabriella

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial

Pignata, S., Scambia, G., Ferrandina, G., Savarese, A., Sorio, R., Breda, E., Gebbia, V., Musso, P., Frigerio, L., Del Medico, P., et al. (2011) · Journal of Clinical Oncology

Ovarian cancer diagnosis and treatmentCancer Treatment and Pharmacology

Cited by 229

Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells

Rosanò, L., Cianfrocca, R., Spinella, F., Di Castro, V., Nicotra, M. R., Lucidi, A., Ferrandina, G., Natali, P. G., & Bagnato, A. (2011) · Clinical Cancer Research

Cancer Cells and MetastasisNitric Oxide and Endothelin Effects

Cited by 187

Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature

Ferrandina, G., Palluzzi, E., Fanfani, F., Gentileschi, S., Valentini, A. L., Mattoli, M. V., Pennacchia, I., Scambia, G., & Zannoni, G. (2016) · World Journal of Surgical Oncology

Endometriosis Research and TreatmentEndometrial and Cervical Cancer Treatments

Cited by 71

Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies

Legge, F., Chiantera, V., Macchia, G., Fagotti, A., Fanfani, F., Ercoli, A., Gallotta, V., Morganti, A. G., Valentini, V., Scambia, G., et al. (2015) · Gynecologic Oncology

Endometrial and Cervical Cancer TreatmentsCervical Cancer and HPV Research

Cited by 43

Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment

Ciucci, A., Zannoni, G. F., Buttarelli, M., Martinelli, E., Mascilini, F., Petrillo, M., Ferrandina, G., Scambia, G., & Gallo, D. (2016) · Oncotarget

Ovarian cancer diagnosis and treatmentImmune cells in cancer

Cited by 27